Alyeska Investment Group Portfolio holdings
AUM
$28.2B
1-Year Return
38.86%
This Quarter Return
+7.83%
1 Year Return
+38.86%
3 Year Return
+101.95%
5 Year Return
+160.93%
10 Year Return
+424.53%
AUM
$12.1B
AUM Growth
-$653M
(-5.1%)
Cap. Flow
-$1.23B
Cap. Flow
% of AUM
-10.11%
Top 10 Holdings %
Top 10 Hldgs %
16.1%
Holding
578
New
140
Increased
94
Reduced
110
Closed
180
Top Buys
| 1 |
IBM
IBM
|
+$272M |
| 2 |
GE Aerospace
GE
|
+$149M |
| 3 |
Analog Devices
ADI
|
+$143M |
| 4 |
KeyCorp
KEY
|
+$131M |
| 5 |
AutoZone
AZO
|
+$120M |
Top Sells
| 1 |
Texas Instruments
TXN
|
+$213M |
| 2 |
GGP
GGP Inc.
GGP
|
+$153M |
| 3 |
General Dynamics
GD
|
+$143M |
| 4 |
Zimmer Biomet
ZBH
|
+$119M |
| 5 |
Teradata
TDC
|
+$106M |
Sector Composition
| 1 | Technology | 18.72% |
| 2 | Industrials | 15.84% |
| 3 | Healthcare | 12.19% |
| 4 | Consumer Discretionary | 11.93% |
| 5 | Financials | 10.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Newmark Group
NMRK
$3.35B
| $1.59M | 0.01% |
+100,000
| New | +$1.59M |
|
|
RDFN
327
DELISTED
Redfin
RDFN
| $1.57M | 0.01% |
+50,000
| New | +$1.57M |
|
328
Akebia Therapeutics
AKBA
$801M
| $1.54M | 0.01% |
103,360
-23,914
| -19% | -$356K |
|
|
CMTA
329
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $1.52M | 0.01% |
80,000
| – | – |
|
330
Visa
V
$659B
| $1.49M | 0.01% |
13,085
-10,367
| -44% | -$1.18M |
|
331
Qualigen Therapeutics
QLGN
$2.97M
| $1.47M | 0.01% |
36
| – | – |
|
|
ACGN
332
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $1.44M | 0.01% |
5,011
+331
| +7% | +$94.9K |
|
|
DATA
333
DELISTED
Tableau Software, Inc.
DATA
| $1.42M | 0.01% |
+20,565
| New | +$1.42M |
|
334
TherapeuticsMD
TXMD
$12.5M
| $1.4M | 0.01% |
4,620
-6,012
| -57% | -$1.82M |
|
335
Universal Technical Institute
UTI
$1.5B
| $1.38M | 0.01% |
575,653
| – | – |
|
336
XWELL
XWEL
$6.39M
| $1.37M | 0.01% |
833
+17
| +2% | +$28K |
|
|
CFRX
337
DELISTED
ContraFect Corporation
CFRX
| $1.33M | 0.01% |
1,643
-120
| -7% | -$96.9K |
|
338
Zymeworks
ZYME
$1.16B
| $1.32M | 0.01% |
173,926
| – | – |
|
|
CLDR
339
DELISTED
Cloudera, Inc.
CLDR
| $1.32M | 0.01% |
79,862
-265,138
| -77% | -$4.38M |
|
|
NITE
340
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $1.31M | 0.01% |
100,000
| – | – |
|
|
NCNA
341
NuCana
NCNA
$5.65M
| $1.26M | 0.01% |
25
| – | – |
|
|
OA
342
DELISTED
Orbital ATK, Inc.
OA
| $1.25M | 0.01% |
+9,511
| New | +$1.25M |
|
343
Voya Financial
VOYA
$7.27B
| $1.23M | 0.01% |
24,778
-344,829
| -93% | -$17.1M |
|
344
TopBuild
BLD
$11.8B
| $1.2M | 0.01% |
+15,807
| New | +$1.2M |
|
345
Stellar Bancorp
STEL
$1.62B
| $1.19M | 0.01% |
+40,000
| New | +$1.19M |
|
346
MediWound
MDWD
$176M
| $1.17M | 0.01% |
37,527
-19,616
| -34% | -$611K |
|
347
Benchmark Electronics
BHE
$1.42B
| $1.14M | 0.01% |
+39,159
| New | +$1.14M |
|
348
vTv Therapeutics
VTVT
$51.6M
| $1.14M | 0.01% |
4,729
-477
| -9% | -$115K |
|
349
Protagonist Therapeutics
PTGX
$3.59B
| $1.04M | 0.01% |
+50,000
| New | +$1.04M |
|
350
Equifax
EFX
$31.2B
| $1.04M | 0.01% |
8,807
-244,984
| -97% | -$28.9M |
|